{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:08:12Z","timestamp":1793387292397,"version":"4.5.0"},"reference-count":473,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>In traditional Chinese medicine (TCM), the liver is the \u201cgeneral organ\u201d that is responsible for governing\/maintaining the free flow of qi over the entire body and storing blood. According to the classic five elements theory, zang\u2013xiang theory, yin\u2013yang theory, meridians and collaterals theory, and the five\u2013viscera correlation theory, the liver has essential relationships with many extrahepatic organs or tissues, such as the mother\u2013child relationships between the liver and the heart, and the yin\u2013yang and exterior\u2013interior relationships between the liver and the gallbladder. The influences of the liver to the extrahepatic organs or tissues have been well-established when treating the extrahepatic diseases from the perspective of modulating the liver by using the ancient classic prescriptions of TCM and the acupuncture and moxibustion. In modern medicine, as the largest solid organ in the human body, the liver has the typical functions of filtration and storage of blood; metabolism of carbohydrates, fats, proteins, hormones, and foreign chemicals; formation of bile; storage of vitamins and iron; and formation of coagulation factors. The liver also has essential endocrine function, and acts as an immunological organ due to containing the resident immune cells. In the perspective of modern human anatomy, physiology, and pathophysiology, the liver has the organ interactions with the extrahepatic organs or tissues, for example, the gut, pancreas, adipose, skeletal muscle, heart, lung, kidney, brain, spleen, eyes, skin, bone, and sexual organs, through the circulation (including hemodynamics, redox signals, hepatokines, metabolites, and the translocation of microbiota or its products, such as endotoxins), the neural signals, or other forms of pathogenic factors, under normal or diseases status. The organ interactions centered on the liver not only influence the homeostasis of these indicated organs or tissues, but also contribute to the pathogenesis of cardiometabolic diseases (including obesity, type 2 diabetes mellitus, metabolic [dysfunction]-associated fatty liver diseases, and cardio-cerebrovascular diseases), pulmonary diseases, hyperuricemia and gout, chronic kidney disease, and male and female sexual dysfunction. Therefore, based on TCM and modern medicine, the liver has the bidirectional interaction with the extrahepatic organ or tissue, and this established bidirectional interaction system may further interact with another one or more extrahepatic organs\/tissues, thus depicting a complex \u201cpan-hepatic network\u201d model. The pan-hepatic network acts as one of the essential mechanisms of homeostasis and the pathogenesis of diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/cjop.cjop-d-22-00131","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T07:21:06Z","timestamp":1703488866000},"page":"401-436","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["The Pan-liver Network Theory"],"prefix":"10.4103","volume":"66","author":[{"given":"Yaxing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Ming","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20240830","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: A clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol Rev"},{"key":"R2-1-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00018.2009","article-title":"The fox genes in the liver: From organogenesis to functional integration","volume":"90","author":"Le Lay","year":"2010","journal-title":"Physiol Rev"},{"key":"R3-1-20240830","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.00027.2008","article-title":"The hepatic microcirculation: Mechanistic contributions and therapeutic targets in liver injury and repair","volume":"89","author":"Vollmar","year":"2009","journal-title":"Physiol Rev"},{"key":"R4-1-20240830","first-page":"e65","article-title":"Cardiohepatic interactions \u2013 From humoral theory to organ transplantation","volume":"102","author":"Silvestre","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"R5-1-20240830","first-page":"6655335","article-title":"Hepatocardiac or cardiohepatic interaction: From traditional Chinese medicine to Western medicine","volume":"2021","author":"Zhang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R6-1-20240830","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"R7-1-20240830","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2015.09.023","article-title":"Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism","volume":"22","author":"Meex","year":"2015","journal-title":"Cell Metab"},{"key":"R8-1-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3803\/EnM.2016.31.1.1","article-title":"The impact of organokines on insulin resistance, inflammation, and atherosclerosis","volume":"31","author":"Choi","year":"2016","journal-title":"Endocrinol Metab (Seoul"},{"key":"R9-1-20240830","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.22123","article-title":"Comprehensive and quantitative proteome profiling of the mouse liver and plasma","volume":"47","author":"Lai","year":"2008","journal-title":"Hepatology"},{"key":"R10-1-20240830","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Meex","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R11-1-20240830","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"Stefan","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"R12-1-20240830","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3390\/nu11081795","article-title":"Identification of the secreted proteins originated from primary human hepatocytes and HepG2 cells","volume":"11","author":"Franko","year":"2019","journal-title":"Nutrients"},{"key":"R13-1-20240830","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab"},{"key":"R14-1-20240830","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41467-020-14450-6","article-title":"Liver governs adipose remodelling via extracellular vesicles in response to lipid overload","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"key":"R15-1-20240830","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12951-021-01137-3","article-title":"Hepatic small extracellular vesicles promote microvascular endothelial hyperpermeability during NAFLD via novel-miRNA-7","volume":"19","author":"Zuo","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"R16-1-20240830","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2019.09.014","article-title":"Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1","volume":"72","author":"Jiang","year":"2020","journal-title":"J Hepatol"},{"key":"R17-1-20240830","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41423-020-00561-z","article-title":"Innate lymphocytes: Pathogenesis and therapeutic targets of liver diseases and cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"R18-1-20240830","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41591-020-0786-7","article-title":"Improving prevention strategies for cardiometabolic disease","volume":"26","author":"Sattar","year":"2020","journal-title":"Nat Med"},{"key":"R19-1-20240830","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehac648","article-title":"Polygenic risk scores for the prediction of cardiometabolic disease","volume":"44","author":"O'Sullivan","year":"2023","journal-title":"Eur Heart J"},{"key":"R20-1-20240830","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(22)00076-6","article-title":"Menopause: A cardiometabolic transition","volume":"10","author":"Nappi","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R21-1-20240830","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1016\/j.cell.2023.08.016","article-title":"Menopause-biology, consequences, supportive care, and therapeutic options","volume":"186","author":"Davis","year":"2023","journal-title":"Cell"},{"key":"R22-1-20240830","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R23-1-20240830","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus \u2013 Mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R24-1-20240830","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","article-title":"Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases","volume":"126","author":"Cai","year":"2020","journal-title":"Circ Res"},{"key":"R25-1-20240830","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCRESAHA.121.319059","article-title":"Nonalcoholic fatty liver disease: An emerging driver of cardiac arrhythmia","volume":"128","author":"Chen","year":"2021","journal-title":"Circ Res"},{"key":"R26-1-20240830","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/HYPERTENSIONAHA.119.13419","article-title":"Nonalcoholic fatty liver disease: An emerging driver of hypertension","volume":"75","author":"Zhao","year":"2020","journal-title":"Hypertension"},{"key":"R27-1-20240830","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1136\/gutjnl-2021-325724","article-title":"Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: Results from a nationwide histology cohort","volume":"71","author":"Simon","year":"2022","journal-title":"Gut"},{"key":"R28-1-20240830","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.1840040622","article-title":"Chronic advanced liver disease and impotence: Cause and effect?","volume":"4","author":"Cornely","year":"1984","journal-title":"Hepatology"},{"key":"R29-1-20240830","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0676.1985.tb00221.x","article-title":"Sexual dysfunction in men with alcoholic liver cirrhosis. A comparative study","volume":"5","author":"Jensen","year":"1985","journal-title":"Liver"},{"key":"R30-1-20240830","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0016-5085(88)80097-0","article-title":"Gonadal dysfunction and inadequate sexual performance in alcoholic cirrhotic men","volume":"95","author":"Gavaler","year":"1988","journal-title":"Gastroenterology"},{"key":"R31-1-20240830","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/hep.1840080246","article-title":"Sexual dysfunction in men with chronic liver disease","volume":"8","author":"Kew","year":"1988","journal-title":"Hepatology"},{"key":"R32-1-20240830","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/0016-5085(90)91139-W","article-title":"Sexual dysfunction in alcoholic cirrhotic men. Copenhagen study group for liver diseases","volume":"98","author":"Gluud","year":"1990","journal-title":"Gastroenterology"},{"key":"R33-1-20240830","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/hep.1840140312","article-title":"Sexual function and testosterone levels in men with nonalcoholic liver disease","volume":"14","author":"Zifroni","year":"1991","journal-title":"Hepatology"},{"key":"R34-1-20240830","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.288.6.698","article-title":"Erectile dysfunction and hepatitis C virus infection","volume":"288","author":"Ferri","year":"2002","journal-title":"JAMA"},{"key":"R35-1-20240830","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/TP.0b013e3181e1f1f6","article-title":"Sexual dysfunction in chronic liver disease: Is liver transplantation an effective cure?","volume":"89","author":"Burra","year":"2010","journal-title":"Transplantation"},{"key":"R36-1-20240830","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/hep.30359","article-title":"Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: Review of pathogenesis and management","volume":"69","author":"Neong","year":"2019","journal-title":"Hepatology"},{"key":"R37-1-20240830","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsxm.2021.11.016","article-title":"Sexual dysfunction in patients with chronic hepatitis B: Prevalence and risk factors","volume":"19","author":"Liao","year":"2022","journal-title":"J Sex Med"},{"key":"R38-1-20240830","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.sxmr.2021.02.002","article-title":"Sexual dysfunction in patients with chronic gastrointestinal and liver diseases: A neglected issue","volume":"10","author":"Romano","year":"2022","journal-title":"Sex Med Rev"},{"key":"R39-1-20240830","doi-asserted-by":"crossref","first-page":"821689","DOI":"10.3389\/fendo.2022.821689","article-title":"A bidirectional relationship between hyperuricemia and metabolic dysfunction-associated fatty liver disease","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol (Lausanne"},{"key":"R40-1-20240830","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nrgastro.2012.79","article-title":"Increased risk of cardiovascular disease and chronic kidney disease in NAFLD","volume":"9","author":"Bonora","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R41-1-20240830","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"R42-1-20240830","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: A multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R43-1-20240830","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/gutjnl-2020-323082","article-title":"Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: An updated meta-analysis","volume":"71","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"R44-1-20240830","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","article-title":"Association of metabolic dysfunction-associated fatty liver disease with kidney disease","volume":"18","author":"Wang","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"R45-1-20240830","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/hep.31770","article-title":"Pulmonary abnormalities in liver disease: Relevance to transplantation and outcome","volume":"74","author":"Raevens","year":"2021","journal-title":"Hepatology"},{"key":"R46-1-20240830","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3109\/15412555.2012.727922","article-title":"Fetuin-A is associated with disease severity and exacerbation frequency in patients with COPD","volume":"10","author":"Minas","year":"2013","journal-title":"COPD"},{"key":"R47-1-20240830","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3350\/cmh.2020.0174","article-title":"Liver-lung axes in alcohol-related liver disease","volume":"26","author":"Arteel","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"R48-1-20240830","doi-asserted-by":"crossref","first-page":"802783","DOI":"10.3389\/fcvm.2022.802783","article-title":"Noble gases therapy in cardiocerebrovascular diseases: The novel stars?","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R49-1-20240830","doi-asserted-by":"crossref","first-page":"8786424","DOI":"10.1155\/2020\/8786424","article-title":"Si-Wu-Tang alleviates nonalcoholic fatty liver disease via blocking TLR4-JNK and Caspase-8-GSDMD signaling pathways","volume":"2020","author":"Zhang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"R50-1-20240830","first-page":"65","article-title":"Five-viscera correlation theory replacing five-element theory","volume":"5","author":"Deng","year":"1988","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"key":"R51-1-20240830","first-page":"7","article-title":"Study on the theory of five organs correlation-from five elements to five organs correlation","volume":"10","author":"Deng","year":"2008","journal-title":"Strateg Study CAE"},{"key":"R52-1-20240830","first-page":"1","article-title":"The discuss on Chinese medical science theory about correlation of five viscera","volume":"24","author":"Qiu","year":"2007","journal-title":"J Hubei Minzu Univ (Med Ed"},{"key":"R53-1-20240830","first-page":"110","article-title":"Research on heart-liver correlation in Yin-Yang, Qi-blood, meridians from The Yellow Emperor's Canon of Medicine","volume":"14","author":"Sun","year":"2012","journal-title":"J Liaoning Univ Tradit Chin Med"},{"key":"R54-1-20240830","first-page":"488","article-title":"Liver-lung interactions in critical illness","volume":"2","author":"Matuschak","year":"1994","journal-title":"New Horiz"},{"key":"R55-1-20240830","first-page":"2997","article-title":"Linkage between liver theory of traditional Chinese medicine and theory of modern medicine","volume":"33","author":"Lin","year":"2015","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R56-1-20240830","first-page":"1656","article-title":"Preliminary study on the essence of Hun in traditional Chinese medicine ( )","volume":"24","author":"Hao","year":"2018","journal-title":"J Basic Chin Med"},{"key":"R57-1-20240830","first-page":"3908","article-title":"Discourse on 'liver storing ethereal soul' and 'lung storing corporeal soul'","volume":"31","author":"Yang","year":"2016","journal-title":"China J Tradit Chin Med Pharm"},{"key":"R58-1-20240830","first-page":"14","article-title":"Discussion on the correlation between the theory of \u201cliver storing soul\u201d in the five spirits of traditional Chinese medicine and insomnia ( \u201d \u201d )","volume":"31","author":"Ou","year":"2015","journal-title":"Hunan J Tradit Chin Med"},{"key":"R59-1-20240830","first-page":"118","article-title":"Fang Yaozhong's experience in treating insomnia from the perspective of liver not hiding soul ( )","volume":"14","author":"Qi","year":"1993","journal-title":"Shaanxi J Tradit Chin Med"},{"key":"R60-1-20240830","first-page":"1664","article-title":"Treatment of insomnia from the perspective of \u201cliver hiding soul\u201d ( \u201c \u201d )","volume":"27","author":"Chen","year":"2021","journal-title":"J Basic Chin Med"},{"key":"R61-1-20240830","first-page":"322","article-title":"Exploring the treatment of polynesia based on the concept of \u201cliver hiding soul\u201d ( \u201c \u201d )","volume":"46","author":"Wang","year":"2022","journal-title":"J Shandong Univ Tradit Chin Med"},{"key":"R62-1-20240830","first-page":"1","article-title":"Ideas and methods for inheriting and innovating five organs correlation theory in traditional Chinese medicine ( )","volume":"38","author":"Xu","year":"2006","journal-title":"New Chin Med"},{"key":"R63-1-20240830","first-page":"46","article-title":"Discussion on the methods and ideas of Deng Tietao's five-zang correlation theory ( )","volume":"19","author":"Chen","year":"2006","journal-title":"Tradit Chin Med Res"},{"key":"R64-1-20240830","first-page":"475","article-title":"A preliminary study on the inheritance and innovation of five organs correlation theory in traditional Chinese medicine ( \u201c \u201d )","volume":"25","author":"Xu","year":"2008","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"key":"R65-1-20240830","first-page":"50","article-title":"Phlegm and blood stasis theory and differentiation and treatment of coronary heart disease ( )","volume":"36","author":"Fang","year":"2013","journal-title":"Guangxi J Tradit Chin Med"},{"key":"R66-1-20240830","first-page":"1","article-title":"Observation on the therapeutic effect of by Yi Qi Chu Tan Fang on 52 cases of coronary heart disease ( )","volume":"11","author":"Fang","year":"1988","journal-title":"Guangxi J Tradit Chin Med"},{"key":"R67-1-20240830","first-page":"1","article-title":"Key points of treating gallstone disease based on the liver ( \u201d \u201d )","volume":"60","author":"Zhu","year":"2007","journal-title":"Acad J Shanghai Univ Tradit Chin Med"},{"key":"R68-1-20240830","first-page":"268","article-title":"Exploration and application innovation of the theory of \u201ctreating gallbladder diseases from the liver\u201d (\u201c \u201d )","volume":"19","author":"Huang","year":"2019","journal-title":"World Latest Med Inf"},{"key":"R69-1-20240830","first-page":"80","article-title":"Therapeutic effects of soothing the liver and regulating qi, nourishing and softening the liver, and clearing liver fire and removing dampness in quinea pig model of cholelithiasis","volume":"36","author":"Liu","year":"2017","journal-title":"J Anhui Univ Chin Med"},{"key":"R70-1-20240830","first-page":"63","article-title":"Effect of modified Chaihu Shugansan on gallbladder function and inflammatory cytokines levels in treatment of chronic cholecystitis cholelithiasis","volume":"27","author":"Cao","year":"2021","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"R71-1-20240830","first-page":"21","article-title":"Analysis of TCM syndrome differentiation and medication for gallstone disease ( )","volume":"43","author":"Wang","year":"2014","journal-title":"Heilongjiang J Tradit Chin Med"},{"key":"R73-1-20240830","first-page":"1193","article-title":"Treatment of 63 cases of gallstones in the gallbladder by Chai-Hu-Shu-Gan-San ( )","volume":"6","author":"Mi","year":"2008","journal-title":"Chin Med Mod Distance Educ Chin"},{"key":"R74-1-20240830","first-page":"503","article-title":"Discussion on the treatment of heart diseases from the perspective of the liver ( )","volume":"10","author":"Zhao","year":"2015","journal-title":"World Chin Med"},{"key":"R75-1-20240830","first-page":"1767","article-title":"Analysis of professor Xu Fengqin's experience in treating coronary heart disease from the perspective of the liver ( )","volume":"19","author":"Ji","year":"2021","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"R76-1-20240830","first-page":"412","article-title":"Research on ancient literature of treating heart diseases from the perspective of the liver ( )","volume":"20","author":"Wang","year":"2014","journal-title":"J Basic Chin Med"},{"key":"R77-1-20240830","doi-asserted-by":"crossref","first-page":"1549658","DOI":"10.1155\/2016\/1549658","article-title":"Effectiveness of acupressure on the Taichong acupoint in lowering blood pressure in patients with hypertension: A randomized clinical trial","volume":"2016","author":"Lin","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"R78-1-20240830","first-page":"616","article-title":"Treatment of hypertension from liver","volume":"35","author":"Liu","year":"2019","journal-title":"J Changchun Univ Chin Med"},{"key":"R79-1-20240830","first-page":"129","article-title":"Diagnosis and treatment of hypertension by traditional Chinese medicine ( )","volume":"6","author":"Zhang","year":"2010","journal-title":"Asia Pac Tradit Med"},{"key":"R80-1-20240830","first-page":"1831","article-title":"Discussion on the treatment of youth hypertension from the perspective of the liver ( )","volume":"18","author":"Sun","year":"2020","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"R81-1-20240830","first-page":"308","article-title":"Treatment of 30 cases of hypertension by Tianma-Gouteng-Yin and captopril ( )","volume":"315","author":"Fang","year":"2008","journal-title":"Shaanxi J Tradit Chin Med"},{"key":"R82-1-20240830","first-page":"1055","article-title":"Literature research on acupuncture point selection for hypertension","volume":"55","author":"Liu","year":"2014","journal-title":"J Tradit Chin Med"},{"key":"R83-1-20240830","first-page":"472","article-title":"Research progress on modern biological mechanism of acupuncture and moxibustion for preventing and treating essential hypertension ( )","volume":"20","author":"Liu","year":"2022","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"R84-1-20240830","first-page":"462","article-title":"Observation on therapeutic effect of acupuncture in the treatment of German hypertension patients","volume":"35","author":"Chen","year":"2010","journal-title":"Zhen Ci Yan Jiu"},{"key":"R85-1-20240830","first-page":"919","article-title":"A randomized controlled clinical study on acupuncture at Taichong point for the treatment of hypertension with hyperactivity of liver yang ( )","volume":"35","author":"Li","year":"2008","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R86-1-20240830","first-page":"999","article-title":"Clinical observation on 30 hypertension patients of liver yang hyperactivity treated by acupuncture at Taichong (LR3)","volume":"50","author":"Hao","year":"2009","journal-title":"J Tradit Chin Med"},{"key":"R87-1-20240830","first-page":"38","article-title":"Clinical application of Taichong acupoint","volume":"20","author":"Rao","year":"2000","journal-title":"J Tradit Chin Med"},{"key":"R88-1-20240830","doi-asserted-by":"crossref","first-page":"e25668","DOI":"10.1097\/MD.0000000000025668","article-title":"Clinical study on acupuncture treatment of hypertension with hyperactivity of liver yang","volume":"100","author":"Wu","year":"2021","journal-title":"Medicine (Baltimore"},{"key":"R89-1-20240830","first-page":"1191","article-title":"Twisting acupuncture and sham acupuncture at Taichong (LR 3) in patients with essential hypertension: An fMRI study","volume":"34","author":"Sun","year":"2014","journal-title":"Zhongguo Zhen Jiu"},{"key":"R90-1-20240830","first-page":"9945277","article-title":"Acupuncture attenuates blood pressure via inducing the expression of nNOS","volume":"2021","author":"Wang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R91-1-20240830","doi-asserted-by":"crossref","first-page":"9541079","DOI":"10.1155\/2019\/9541079","article-title":"Gene-level regulation of acupuncture therapy in spontaneously hypertensive rats: A whole transcriptome analysis","volume":"2019","author":"Ma","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"R92-1-20240830","first-page":"74","article-title":"Effect of Taichong (LR 3) acupuncture in spontaneously hypertensive rats","volume":"39","author":"Luo","year":"2019","journal-title":"J Tradit Chin Med"},{"key":"R93-1-20240830","doi-asserted-by":"crossref","first-page":"8696402","DOI":"10.1155\/2017\/8696402","article-title":"Acupuncture attenuates renal sympathetic activity and blood pressure via beta-adrenergic receptors in spontaneously hypertensive rats","volume":"2017","author":"Yang","year":"2017","journal-title":"Neural Plast"},{"key":"R94-1-20240830","first-page":"204367","article-title":"MicroRNA profiling response to acupuncture therapy in spontaneously hypertensive rats","volume":"2015","author":"Wang","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"key":"R95-1-20240830","first-page":"791","article-title":"Effects of twirling-rotating reinforcing and reducing technique for left ventricular morphology, concentration of ET-1 and expression of type I, III collagen mRNA in spontaneous hypertensive rats","volume":"34","author":"Zhang","year":"2014","journal-title":"Zhongguo Zhen Jiu"},{"key":"R96-1-20240830","doi-asserted-by":"crossref","first-page":"e44216","DOI":"10.1371\/journal.pone.0044216","article-title":"Proteomic response to acupuncture treatment in spontaneously hypertensive rats","volume":"7","author":"Lai","year":"2012","journal-title":"PLoS One"},{"key":"R97-1-20240830","first-page":"36","article-title":"Effect of moderate acupuncture-stimulation of \u201cTaichong\u201d (LR 3) on blood pressure and plasma endothelin-1 levels in spontaneous hypertension rats","volume":"36","author":"Wang","year":"2011","journal-title":"Zhen Ci Yan Jiu"},{"key":"R98-1-20240830","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.117.09759","article-title":"Inhibition of NADPH oxidase-dependent oxidative stress in the rostral ventrolateral medulla mediates the antihypertensive effects of acupuncture in spontaneously hypertensive rats","volume":"71","author":"Wang","year":"2018","journal-title":"Hypertension"},{"key":"R99-1-20240830","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/acu.2020.1422","article-title":"Acupuncture for hypertension using traditional Chinese medicine concepts","volume":"33","author":"Sudhakaran","year":"2021","journal-title":"Med Acupunct"},{"key":"R100-1-20240830","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1161\/01.HYP.0000252841.65818.04","article-title":"Hasty conclusion about acupuncture for hypertension?","volume":"49","author":"Moffet","year":"2007","journal-title":"Hypertension"},{"key":"R101-1-20240830","first-page":"60","article-title":"Analysis of the syndrome mechanism of treating chest bi from the perspective of the liver ( )","volume":"33","author":"Wei","year":"2016","journal-title":"Inf Tradit Chin Med"},{"key":"R102-1-20240830","first-page":"12","article-title":"Treatment of coronary heart disease from five viscera correlation ( )","volume":"17","author":"Zhao","year":"1999","journal-title":"J Sichuan Tradit Chin Med"},{"key":"R103-1-20240830","first-page":"2288","article-title":"Analysis of the original meaning of the three prescriptions of Gualou Xiebai in treating chest bi from Jin-Gui-Yao-Lue ( )","volume":"32","author":"Xu","year":"2017","journal-title":"China J Tradit Chin Med Pharm"},{"key":"R104-1-20240830","first-page":"24","article-title":"Analysis of the treatment of palpitation based on the liver syndrome differentiation ( )","volume":"29","author":"Chen","year":"2010","journal-title":"Inner Mong J Tradit Chin Med"},{"key":"R105-1-20240830","first-page":"911","article-title":"Treating arrhythmias from the liver ( )","volume":"26","author":"Luo","year":"2004","journal-title":"Hebei J Tradit Chin Med"},{"key":"R106-1-20240830","first-page":"56","article-title":"Treating palpitations from the liver ( )","volume":"32","author":"Yin","year":"2012","journal-title":"Henan Tradit Chin Med"},{"key":"R107-1-20240830","first-page":"520","article-title":"Textual research on the treatment of chest-bi based on the liver ( )","volume":"22","author":"Cao","year":"2004","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R108-1-20240830","first-page":"280","article-title":"Discussion on treating palpitation from the perspective of the liver( )","volume":"25","author":"Jiao","year":"2003","journal-title":"Hebei J Tradit Chin Med"},{"key":"R109-1-20240830","first-page":"224","article-title":"Experience in treating chest-bi and heart pain from the perspective of the liver ( )","volume":"17","author":"Deng","year":"2017","journal-title":"World Latest Med Inf"},{"key":"R111-1-20240830","first-page":"41","article-title":"ZHANG Zhenyu's experience on treating spleen and stomach diseases from liver","volume":"49","author":"Zhang","year":"2022","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R112-1-20240830","first-page":"40","article-title":"Discussion on the treatment of ulcerative colitis from the perspective of the liver ( )","volume":"33","author":"Li","year":"2015","journal-title":"J Sichuan Tradit Chin Med"},{"key":"R113-1-20240830","first-page":"1589","article-title":"Experience of professor WANG Xin-yue in treating ulcerative colitis from liver","volume":"27","author":"Yang","year":"2012","journal-title":"China J Tradit Chin Med Pharm"},{"key":"R114-1-20240830","first-page":"1733","article-title":"Tracing the source of literature on the treatment of ulcerative colitis from the perspective of the liver ( )","volume":"11","author":"Huang","year":"2018","journal-title":"Glob Tradit Chin Med"},{"key":"R115-1-20240830","first-page":"27","article-title":"Analysis of the treatment of diarrhea from the five zang organs in Huang-Di-Nei-Jing ( )","volume":"27","author":"Fang","year":"2020","journal-title":"Chin J Rural Med Pharm"},{"key":"R116-1-20240830","first-page":"651","article-title":"Experience in treating functional constipation from the perspective of the liver ( )","volume":"45","author":"Zhang","year":"2023","journal-title":"Hebei J Tradit Chin Med"},{"key":"R117-1-20240830","first-page":"879","article-title":"Brief analysis of treating constipation starting from liver","volume":"28","author":"Wang","year":"2016","journal-title":"Clin J Tradit Chin Med"},{"key":"R119-1-20240830","first-page":"12","article-title":"A brief analysis of thoughts on treating lung diseases from the liver ( )","volume":"53","author":"Li","year":"2022","journal-title":"Jiangxi J Tradit Chin Med"},{"key":"R122-1-20240830","first-page":"180","article-title":"Introduction to Luo Ren's academic thought and clinical experience in diagnosis and treatment of nephropathy ( )","volume":"49","author":"Ji","year":"2017","journal-title":"New Chin Med"},{"key":"R123-1-20240830","first-page":"116","article-title":"Theoretical discussion on treating knee osteoarthritis from the liver ( )","volume":"35","author":"Li","year":"2019","journal-title":"Hunan J Tradit Chin Med"},{"key":"R124-1-20240830","first-page":"197","article-title":"Shi Qi's treatment of knee osteoarthritis from the perspective of the liver and kidney ( )","volume":"54","author":"Li","year":"2013","journal-title":"J Tradit Chin Med"},{"key":"R125-1-20240830","first-page":"1488","article-title":"Treatment of stroke based on the liver from different stage ( )","volume":"63","author":"Shi","year":"2022","journal-title":"J Tradit Chin Med"},{"key":"R126-1-20240830","first-page":"1126","article-title":"Discussion on the treatment of the brain diseases based on the liver ( )","volume":"22","author":"Yang","year":"2004","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R127-1-20240830","first-page":"113","article-title":"Treating tinnitus and deafness from the perspective of the liver ( )","volume":"171","author":"Zheng","year":"2008","journal-title":"J Shandong Univ Tradit Chin Med"},{"key":"R128-1-20240830","first-page":"42","article-title":"Summary of treating ear diseases from the perspective of the liver ( )","volume":"19","author":"Li","year":"2000","journal-title":"Chin Arch Tradit Chin Med"},{"key":"R131-1-20240830","first-page":"1575","article-title":"Professor Wang Xingkuan's experience in treating allergic rhinitis from the liver ( )","volume":"25","author":"Wu","year":"2010","journal-title":"Guangming J Chin Med"},{"key":"R132-1-20240830","first-page":"19","article-title":"Discussion on the treatment of rhinitis from the liver ( )","volume":"21","author":"Peng","year":"1988","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"R133-1-20240830","first-page":"392","article-title":"Discussion on the differentiation and treatment of dry eye syndrome in traditional Chinese medicine ( )","volume":"41","author":"Wang","year":"2021","journal-title":"Henan Tradit Chin Med"},{"key":"R134-1-20240830","first-page":"175","article-title":"The therapeutic effect of Qiju-Dihuang-Tang on dry eye patients with liver and kidney yin deficiency and its effect on tear secretion ( )","volume":"24","author":"Tao","year":"2018","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"R135-1-20240830","first-page":"1372","article-title":"Analysis of Fu Qingzhu's gynecology treated mentrual disease from the liver","volume":"38","author":"Shen","year":"2018","journal-title":"Jilin J Chin Med"},{"key":"R136-1-20240830","first-page":"2517","article-title":"Dysmenorrhea treatment from perspective of liver in Fu Qing Zhu NYU Ke","volume":"35","author":"Sun","year":"2020","journal-title":"Acta Chin Med"},{"key":"R137-1-20240830","first-page":"1916","article-title":"View on the traditional Chinese medicine treatment principle and prescription of premature ovarian failure from the liver theory","volume":"29","author":"Chen","year":"2014","journal-title":"China J Tradit Chin Med Pharm"},{"key":"R138-1-20240830","first-page":"987","article-title":"Treatment of woman abundant breast from liver and kidney","volume":"28","author":"Peng","year":"2013","journal-title":"China J Tradit Chin Med Pharm"},{"key":"R139-1-20240830","first-page":"929","article-title":"Discussion the treatment of breast disease from the theory based on \u201cbreast is the opening of liver\u201d","volume":"43","author":"Wang","year":"2022","journal-title":"Shaanxi J Tradit Chin Med"},{"key":"R140-1-20240830","first-page":"262","article-title":"Discussion on treatment of female sexual dysfunction from the liver( )","volume":"43","author":"Zhou","year":"2008","journal-title":"Zhejiang J Tradit Chin Med"},{"key":"R143-1-20240830","first-page":"58","article-title":"Study of Shugan Yiyang capsule on erectile dysfunction","volume":"30","author":"Wang","year":"2005","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R144-1-20240830","first-page":"27","article-title":"Discussion on treating infertility from liver in FU Qingzhu's obstetrics and gynecology","volume":"23","author":"Wu","year":"2021","journal-title":"J Liaoning Univ Tradit Chin Med"},{"key":"R145-1-20240830","first-page":"61","article-title":"Observation on 60 cases of infertility treated from the liver ( )","volume":"10","author":"Yu","year":"2004","journal-title":"J Basic Chin Med"},{"key":"R146-1-20240830","first-page":"27","article-title":"Treatment of male infertility from the liver ( )","volume":"9","author":"Zhang","year":"1987","journal-title":"Hebei J Tradit Chin Med"},{"key":"R147-1-20240830","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s42255-019-0145-5","article-title":"Inter-organ cross-talk in metabolic syndrome","volume":"1","author":"Priest","year":"2019","journal-title":"Nat Metab"},{"key":"R148-1-20240830","doi-asserted-by":"crossref","first-page":"101138","DOI":"10.1016\/j.molmet.2020.101138","article-title":"Hepatokines and metabolism: Deciphering communication from the liver","volume":"44","author":"Jensen-Cody","year":"2021","journal-title":"Mol Metab"},{"key":"R149-1-20240830","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3390\/biomedicines9121903","article-title":"Hepatokines and non-alcoholic fatty liver disease: Linking liver pathophysiology to metabolism","volume":"9","author":"Kim","year":"2021","journal-title":"Biomedicines"},{"key":"R150-1-20240830","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: Regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"R151-1-20240830","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr"},{"key":"R152-1-20240830","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R153-1-20240830","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fendo.2014.00107","article-title":"FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases","volume":"5","author":"Itoh","year":"2014","journal-title":"Front Endocrinol (Lausanne"},{"key":"R154-1-20240830","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00330.2013","article-title":"Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine","volume":"306","author":"Keipert","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R155-1-20240830","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.3249","article-title":"FGF21 regulates metabolism and circadian behavior by acting on the nervous system","volume":"19","author":"Bookout","year":"2013","journal-title":"Nat Med"},{"key":"R156-1-20240830","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat Commun"},{"key":"R157-1-20240830","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab"},{"key":"R158-1-20240830","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.3014","article-title":"Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine","volume":"19","author":"Kim","year":"2013","journal-title":"Nat Med"},{"key":"R159-1-20240830","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00011-019-01271-7","article-title":"Organ crosstalk: The potent roles of inflammation and fibrotic changes in the course of organ interactions","volume":"68","author":"Armutcu","year":"2019","journal-title":"Inflamm Res"},{"key":"R160-1-20240830","doi-asserted-by":"crossref","first-page":"e47903","DOI":"10.15252\/embr.201947903","article-title":"Inter-organ communication: A gatekeeper for metabolic health","volume":"20","author":"Castillo-Armengol","year":"2019","journal-title":"EMBO Rep"},{"key":"R161-1-20240830","doi-asserted-by":"crossref","first-page":"L42","DOI":"10.1152\/ajplung.00209.2021","article-title":"An American Physiological Society cross-journal call for papers on \u201cinter-organ communication in homeostasis and disease\u201d","volume":"321","author":"Bodine","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R162-1-20240830","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1152\/physrev.1929.9.3.399","article-title":"Organization for physiological homeostasis","volume":"IX","author":"Cannon","year":"1929","journal-title":"Physiol Rev"},{"key":"R163-1-20240830","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/scel.1993.1027","article-title":"Inter-organ communication between intestine and liver in vivo and in vitro","volume":"4","author":"Plauth","year":"1993","journal-title":"Semin Cell Biol"},{"key":"R164-1-20240830","first-page":"261","article-title":"Gut microbiota in liver disease: What do we know and what do we not know?","volume":"35","author":"Jiang","year":"2020","journal-title":"Physiology (Bethesda"},{"key":"R165-1-20240830","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","article-title":"The gut-liver axis and the intersection with the microbiome","volume":"15","author":"Tripathi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R166-1-20240830","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease-the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"R167-1-20240830","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-nutr-071816-064732","article-title":"Trimethylamine N-oxide, the microbiome, and heart and kidney disease","volume":"37","author":"Zeisel","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"R168-1-20240830","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2021.02.011","article-title":"Bile formation and secretion: An update","volume":"75","author":"Boyer","year":"2021","journal-title":"J Hepatol"},{"key":"R169-1-20240830","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cphy.c120027","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr Physiol"},{"key":"R170-1-20240830","first-page":"G617","article-title":"Glutathione as a primary osmotic driving force in hepatic bile formation","volume":"263","author":"Ballatori","year":"1992","journal-title":"Am J Physiol"},{"key":"R171-1-20240830","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu Rev Nutr"},{"key":"R172-1-20240830","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.physiol.64.082201.100300","article-title":"Bile salt transporters","volume":"64","author":"Meier","year":"2002","journal-title":"Annu Rev Physiol"},{"key":"R173-1-20240830","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: Molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol Rev"},{"key":"R174-1-20240830","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrendo.2014.60","article-title":"Beyond intestinal soap \u2013 Bile acids in metabolic control","volume":"10","author":"Kuipers","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"R175-1-20240830","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol Rev"},{"key":"R176-1-20240830","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"key":"R177-1-20240830","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cld.861","article-title":"Bile acid biology, pathophysiology, and therapeutics","volume":"15","author":"Chiang","year":"2020","journal-title":"Clin Liver Dis (Hoboken"},{"key":"R178-1-20240830","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.celrep.2017.01.014","article-title":"FGF21 Administration suppresses retinal and choroidal neovascularization in mice","volume":"18","author":"Fu","year":"2017","journal-title":"Cell Rep"},{"key":"R179-1-20240830","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med"},{"key":"R180-1-20240830","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/liv.15160","article-title":"Roles for the mycobiome in liver disease","volume":"42","author":"Zeng","year":"2022","journal-title":"Liver Int"},{"key":"R181-1-20240830","doi-asserted-by":"crossref","first-page":"100220","DOI":"10.1016\/j.jhepr.2020.100220","article-title":"Gut dysbiosis as a driver in alcohol-induced liver injury","volume":"3","author":"Fairfield","year":"2021","journal-title":"JHEP Rep"},{"key":"R182-1-20240830","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/hep.31178","article-title":"Fecal microbiome distinguishes alcohol consumption from alcoholic hepatitis but does not discriminate disease severity","volume":"72","author":"Smirnova","year":"2020","journal-title":"Hepatology"},{"key":"R183-1-20240830","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/hep.27489","article-title":"Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice","volume":"61","author":"Chen","year":"2015","journal-title":"Hepatology"},{"key":"R184-1-20240830","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"R185-1-20240830","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","article-title":"Intestinal fungi contribute to development of alcoholic liver disease","volume":"127","author":"Yang","year":"2017","journal-title":"J Clin Invest"},{"key":"R186-1-20240830","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30832","article-title":"Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis","volume":"71","author":"Lang","year":"2020","journal-title":"Hepatology"},{"key":"R187-1-20240830","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jhep.2019.09.029","article-title":"The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease","volume":"72","author":"Chu","year":"2020","journal-title":"J Hepatol"},{"key":"R188-1-20240830","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"R189-1-20240830","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","article-title":"Intestinal virome signature associated with severity of nonalcoholic fatty liver disease","volume":"159","author":"Lang","year":"2020","journal-title":"Gastroenterology"},{"key":"R190-1-20240830","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jhep.2021.11.029","article-title":"The fecal mycobiome in non-alcoholic fatty liver disease","volume":"76","author":"Demir","year":"2022","journal-title":"J Hepatol"},{"key":"R191-1-20240830","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","article-title":"Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice","volume":"62","author":"Le Roy","year":"2013","journal-title":"Gut"},{"key":"R192-1-20240830","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"R193-1-20240830","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"R194-1-20240830","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1053\/j.gastro.2012.01.034","article-title":"A high-fat diet is associated with endotoxemia that originates from the gut","volume":"142","author":"Pendyala","year":"2012","journal-title":"Gastroenterology"},{"key":"R195-1-20240830","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"R196-1-20240830","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"R197-1-20240830","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","article-title":"Altered profile of human gut microbiome is associated with cirrhosis and its complications","volume":"60","author":"Bajaj","year":"2014","journal-title":"J Hepatol"},{"key":"R198-1-20240830","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"R199-1-20240830","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R200-1-20240830","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41575-018-0099-1","article-title":"Alcohol, liver disease and the gut microbiota","volume":"16","author":"Bajaj","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R201-1-20240830","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R202-1-20240830","doi-asserted-by":"crossref","first-page":"e76554","DOI":"10.7554\/eLife.76554","article-title":"Gut microbial trimethylamine is elevated in alcohol-associated hepatitis and contributes to ethanol-induced liver injury in mice","volume":"11","author":"Helsley","year":"2022","journal-title":"Elife"},{"key":"R203-1-20240830","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1073\/pnas.0601056103","article-title":"Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice","volume":"103","author":"Dumas","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R204-1-20240830","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"R205-1-20240830","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"R206-1-20240830","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2010.11.049","article-title":"Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency","volume":"140","author":"Spencer","year":"2011","journal-title":"Gastroenterology"},{"key":"R207-1-20240830","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","article-title":"Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"R208-1-20240830","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1172\/JCI94601","article-title":"l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans","volume":"129","author":"Koeth","year":"2019","journal-title":"J Clin Invest"},{"key":"R209-1-20240830","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"R210-1-20240830","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/nu9111220","article-title":"Nonalcoholic fatty liver disease is exacerbated in high-fat diet-fed gnotobiotic mice by colonization with the gut microbiota from patients with nonalcoholic steatohepatitis","volume":"9","author":"Chiu","year":"2017","journal-title":"Nutrients"},{"key":"R211-1-20240830","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41591-018-0061-3","article-title":"Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women","volume":"24","author":"Hoyles","year":"2018","journal-title":"Nat Med"},{"key":"R212-1-20240830","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","article-title":"Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease","volume":"65","author":"Llopis","year":"2016","journal-title":"Gut"},{"key":"R213-1-20240830","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/dmm.017400","article-title":"How informative is the mouse for human gut microbiota research?","volume":"8","author":"Nguyen","year":"2015","journal-title":"Dis Model Mech"},{"key":"R214-1-20240830","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/gutjnl-2011-301012","article-title":"Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota","volume":"61","author":"Serino","year":"2012","journal-title":"Gut"},{"key":"R215-1-20240830","doi-asserted-by":"crossref","first-page":"20458940211054304","DOI":"10.1177\/20458940211054304","article-title":"Liver abnormalities in pulmonary arterial hypertension","volume":"11","author":"Nickel","year":"2021","journal-title":"Pulm Circ"},{"key":"R216-1-20240830","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"R217-1-20240830","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1507\/endocrj.EJ18-0241","article-title":"Regulation of compensatory \u03b2-cell proliferation by inter-organ networks from the liver to pancreatic \u03b2-cells","volume":"65","author":"Imai","year":"2018","journal-title":"Endocr J"},{"key":"R218-1-20240830","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.1163971","article-title":"Regulation of pancreatic beta cell mass by neuronal signals from the liver","volume":"322","author":"Imai","year":"2008","journal-title":"Science"},{"key":"R219-1-20240830","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1038\/s41467-017-01869-7","article-title":"Neuronal signals regulate obesity induced \u03b2-cell proliferation by FoxM1 dependent mechanism","volume":"8","author":"Yamamoto","year":"2017","journal-title":"Nat Commun"},{"key":"R220-1-20240830","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/cib.2.5.9053","article-title":"Neural relay from the liver induces proliferation of pancreatic beta cells: A path to regenerative medicine using the self-renewal capabilities","volume":"2","author":"Katagiri","year":"2009","journal-title":"Commun Integr Biol"},{"key":"R221-1-20240830","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/intimm\/dxab023","article-title":"Regulation of systemic metabolism by the autonomic nervous system consisting of afferent and efferent innervation","volume":"34","author":"Imai","year":"2022","journal-title":"Int Immunol"},{"key":"R222-1-20240830","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.celrep.2013.01.007","article-title":"Liver-derived systemic factors drive \u03b2 cell hyperplasia in insulin-resistant states","volume":"3","author":"El Ouaamari","year":"2013","journal-title":"Cell Rep"},{"key":"R223-1-20240830","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cmet.2015.12.001","article-title":"SerpinB1 promotes pancreatic \u03b2 cell proliferation","volume":"23","author":"El Ouaamari","year":"2016","journal-title":"Cell Metab"},{"key":"R224-1-20240830","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41467-017-01863-z","article-title":"Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models","volume":"8","author":"Mita","year":"2017","journal-title":"Nat Commun"},{"key":"R225-1-20240830","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bbrc.2019.06.124","article-title":"Hepatocytes derived extracellular vesicles from high-fat diet induced obese mice modulate genes expression and proliferation of islet \u03b2 cells","volume":"516","author":"Fu","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"R226-1-20240830","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.cmet.2017.05.011","article-title":"Interrupted glucagon signaling reveals hepatic \u03b1 cell axis and role for L-glutamine in \u03b1 cell proliferation","volume":"25","author":"Dean","year":"2017","journal-title":"Cell Metab"},{"key":"R227-1-20240830","doi-asserted-by":"crossref","first-page":"E671","DOI":"10.1152\/ajpendo.00492.2002","article-title":"Glucagon and regulation of glucose metabolism","volume":"284","author":"Jiang","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R228-1-20240830","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.cmet.2017.05.006","article-title":"Amino acid transporter Slc38a5 controls glucagon receptor inhibition-induced pancreatic \u03b1 cell hyperplasia in mice","volume":"25","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"key":"R229-1-20240830","doi-asserted-by":"crossref","first-page":"E920","DOI":"10.1152\/ajpendo.00459.2019","article-title":"Alanine, arginine, cysteine, and proline, but not glutamine, are substrates for, and acute mediators of, the liver-\u03b1-cell axis in female mice","volume":"318","author":"Galsgaard","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R230-1-20240830","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","article-title":"Adipose tissue-liver cross talk in the control of whole-body metabolism: Implications in nonalcoholic fatty liver disease","volume":"158","author":"Azzu","year":"2020","journal-title":"Gastroenterology"},{"key":"R231-1-20240830","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: Revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"R232-1-20240830","first-page":"1237","article-title":"Adipokines in non-alcoholic fatty liver disease: Are we on the road toward new biomarkers and therapeutic targets?","volume":"11","author":"Francisco","year":"2022","journal-title":"Biology (Basel"},{"key":"R233-1-20240830","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.cmet.2013.04.012","article-title":"Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production","volume":"17","author":"Cao","year":"2013","journal-title":"Cell Metab"},{"key":"R234-1-20240830","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/hep.28659","article-title":"Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice","volume":"64","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"R235-1-20240830","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/hep.28722","article-title":"Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver disease","volume":"64","author":"Romeo","year":"2016","journal-title":"Hepatology"},{"key":"R236-1-20240830","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41467-021-22106-2","article-title":"Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver","volume":"12","author":"Kim","year":"2021","journal-title":"Nat Commun"},{"key":"R237-1-20240830","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"R238-1-20240830","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"R239-1-20240830","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"R240-1-20240830","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"key":"R241-1-20240830","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41374-021-00680-9","article-title":"Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice","volume":"102","author":"Yano","year":"2022","journal-title":"Lab Invest"},{"key":"R242-1-20240830","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"R243-1-20240830","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/db08-0392","article-title":"Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice","volume":"58","author":"Xu","year":"2009","journal-title":"Diabetes"},{"key":"R244-1-20240830","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cmet.2011.02.010","article-title":"Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway","volume":"13","author":"Awazawa","year":"2011","journal-title":"Cell Metab"},{"key":"R245-1-20240830","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/j.1440-1746.2009.06039.x","article-title":"Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis","volume":"24","author":"Asano","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R246-1-20240830","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic metabolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"R247-1-20240830","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"R248-1-20240830","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"R249-1-20240830","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-021-05649-3","article-title":"Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice","volume":"65","author":"Moyce Gruber","year":"2022","journal-title":"Diabetologia"},{"key":"R250-1-20240830","doi-asserted-by":"crossref","first-page":"110480","DOI":"10.1016\/j.mce.2019.110480","article-title":"Adiponectin is required for pioglitazone-induced improvements in hepatic steatosis in mice fed a high-fat diet","volume":"493","author":"de Mendon\u00e7a","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"R251-1-20240830","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metab"},{"key":"R252-1-20240830","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/j.gastro.2013.10.059","article-title":"Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"key":"R253-1-20240830","doi-asserted-by":"crossref","first-page":"109128","DOI":"10.1016\/j.celrep.2021.109128","article-title":"Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms","volume":"35","author":"Sostre-Col\u00f3n","year":"2021","journal-title":"Cell Rep"},{"key":"R254-1-20240830","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmet.2018.12.003","article-title":"Hepatic c-Jun regulates glucose metabolism via FGF21 and modulates body temperature through the neural signals","volume":"20","author":"Xiao","year":"2019","journal-title":"Mol Metab"},{"key":"R255-1-20240830","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/db21-0363","article-title":"Hepatic CPT1A facilitates liver-adipose cross-talk via induction of FGF21 in mice","volume":"71","author":"Sun","year":"2021","journal-title":"Diabetes"},{"key":"R256-1-20240830","doi-asserted-by":"crossref","first-page":"19475","DOI":"10.1074\/jbc.RA119.009868","article-title":"Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1\u03b1-FGF21 axis in mice","volume":"294","author":"Aljohani","year":"2019","journal-title":"J Biol Chem"},{"key":"R257-1-20240830","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/cells11101680","article-title":"Hepatic hedgehog signaling participates in the crosstalk between liver and adipose tissue in mice by regulating FGF21","volume":"11","author":"Ott","year":"2022","journal-title":"Cells"},{"key":"R258-1-20240830","doi-asserted-by":"crossref","first-page":"95948","DOI":"10.1172\/jci.insight.95948","article-title":"Hepatic tristetraprolin promotes insulin resistance through RNA destabilization of FGF21","volume":"3","author":"Sawicki","year":"2018","journal-title":"JCI Insight"},{"key":"R259-1-20240830","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.1073\/pnas.1816023116","article-title":"Hepatic posttranscriptional network comprised of CCR4-NOT deadenylase and FGF21 maintains systemic metabolic homeostasis","volume":"116","author":"Morita","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R260-1-20240830","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.31881","article-title":"Hepatic small ubiquitin-related modifier (SUMO)-specific protease 2 controls systemic metabolism through SUMOylation-dependent regulation of liver-adipose tissue crosstalk","volume":"74","author":"Liu","year":"2021","journal-title":"Hepatology"},{"key":"R261-1-20240830","doi-asserted-by":"crossref","first-page":"e2101991","DOI":"10.1002\/advs.202101991","article-title":"Hepatokine pregnancy zone protein governs the diet-induced thermogenesis through activating brown adipose tissue","volume":"8","author":"Lin","year":"2021","journal-title":"Adv Sci (Weinh"},{"key":"R262-1-20240830","doi-asserted-by":"crossref","first-page":"e20201203","DOI":"10.1084\/jem.20201203","article-title":"Feeding-induced hepatokine, manf, ameliorates diet-induced obesity by promoting adipose browning via p38 MAPK pathway","volume":"218","author":"Wu","year":"2021","journal-title":"J Exp Med"},{"key":"R263-1-20240830","doi-asserted-by":"crossref","first-page":"155139","DOI":"10.1016\/j.metabol.2022.155139","article-title":"Bone morphogenic protein 9 is a novel thermogenic hepatokine secreted in response to cold exposure","volume":"129","author":"Um","year":"2022","journal-title":"Metabolism"},{"key":"R264-1-20240830","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1038\/s41467-021-22579-1","article-title":"Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue","volume":"12","author":"Georgiadi","year":"2021","journal-title":"Nat Commun"},{"key":"R265-1-20240830","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat Med"},{"key":"R266-1-20240830","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature26138","article-title":"Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance","volume":"555","author":"Ghorpade","year":"2018","journal-title":"Nature"},{"key":"R267-1-20240830","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/s41467-020-15963-w","article-title":"Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity","volume":"11","author":"Seo","year":"2020","journal-title":"Nat Commun"},{"key":"R268-1-20240830","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1038\/nm.4420","article-title":"A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle","volume":"23","author":"Awazawa","year":"2017","journal-title":"Nat Med"},{"key":"R269-1-20240830","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2337\/db13-0728","article-title":"LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance","volume":"63","author":"Lan","year":"2014","journal-title":"Diabetes"},{"key":"R270-1-20240830","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/JME-17-0267","article-title":"LECT2 promotes inflammation and insulin resistance in adipocytes via P38 pathways","volume":"61","author":"Jung","year":"2018","journal-title":"J Mol Endocrinol"},{"key":"R271-1-20240830","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2337\/db21-0857","article-title":"Hepatokine ERAP1 disturbs skeletal muscle insulin sensitivity via inhibiting USP33-mediated ADRB2 deubiquitination","volume":"71","author":"Niu","year":"2022","journal-title":"Diabetes"},{"key":"R272-1-20240830","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nm.4295","article-title":"Deficiency of the hepatokine selenoprotein P increases responsiveness to exercise in mice through upregulation of reactive oxygen species and AMP-activated protein kinase in muscle","volume":"23","author":"Misu","year":"2017","journal-title":"Nat Med"},{"key":"R273-1-20240830","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2014.09.012","article-title":"Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice","volume":"62","author":"Peyrou","year":"2015","journal-title":"J Hepatol"},{"key":"R274-1-20240830","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.3390\/ijms23073959","article-title":"Hepatic PTEN signaling regulates systemic metabolic homeostasis through hepatokines-mediated liver-to-peripheral organs crosstalk","volume":"23","author":"Berthou","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R275-1-20240830","doi-asserted-by":"crossref","first-page":"e154746","DOI":"10.1172\/jci.insight.154746","article-title":"The hepatokine TSK maintains myofiber integrity and exercise endurance and contributes to muscle regeneration","volume":"7","author":"Wang","year":"2022","journal-title":"JCI Insight"},{"key":"R276-1-20240830","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.30686","article-title":"Sarcopenia in cirrhosis: Looking beyond the skeletal muscle loss to see the systemic disease","volume":"70","author":"Bhanji","year":"2019","journal-title":"Hepatology"},{"key":"R277-1-20240830","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jhep.2021.11.006","article-title":"Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis","volume":"76","author":"Tantai","year":"2022","journal-title":"J Hepatol"},{"key":"R278-1-20240830","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI109322","article-title":"The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia","volume":"63","author":"Lockwood","year":"1979","journal-title":"J Clin Invest"},{"key":"R279-1-20240830","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1073\/pnas.1317049110","article-title":"Hyperammonemia in cirrhosis induces transcriptional regulation of myostatin by an NF-\u03baB-mediated mechanism","volume":"110","author":"Qiu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R280-1-20240830","doi-asserted-by":"crossref","first-page":"E983","DOI":"10.1152\/ajpendo.00183.2012","article-title":"Hyperammonemia-mediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis","volume":"303","author":"Qiu","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R281-1-20240830","doi-asserted-by":"crossref","first-page":"G241","DOI":"10.1152\/ajpgi.00373.2020","article-title":"Sarcopenia in chronic liver disease: Mechanisms and countermeasures","volume":"320","author":"Allen","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R282-1-20240830","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.29107","article-title":"Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis","volume":"65","author":"Kumar","year":"2017","journal-title":"Hepatology"},{"key":"R283-1-20240830","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jhep.2016.07.040","article-title":"Sarcopenia from mechanism to diagnosis and treatment in liver disease","volume":"65","author":"Dasarathy","year":"2016","journal-title":"J Hepatol"},{"key":"R284-1-20240830","doi-asserted-by":"crossref","first-page":"733625","DOI":"10.3389\/fendo.2021.733625","article-title":"Hepatic steatosis contributes to the development of muscle atrophy via inter-organ crosstalk","volume":"12","author":"Pasmans","year":"2021","journal-title":"Front Endocrinol (Lausanne"},{"key":"R285-1-20240830","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1002\/hep.32681","article-title":"Letter to the editor: NAFLD and sarcopenia: Association or causation?","volume":"76","author":"Zhang","year":"2022","journal-title":"Hepatology"},{"key":"R286-1-20240830","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.29910","article-title":"Role of sarcopenia in nonalcoholic fatty liver disease: Definition is crucially important","volume":"68","author":"Peng","year":"2018","journal-title":"Hepatology"},{"key":"R287-1-20240830","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/hep.32578","article-title":"Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study","volume":"76","author":"Sinn","year":"2022","journal-title":"Hepatology"},{"key":"R288-1-20240830","first-page":"R1265","article-title":"Myostatin expression in porcine tissues: Tissue specificity and developmental and postnatal regulation","volume":"275","author":"Ji","year":"1998","journal-title":"Am J Physiol"},{"key":"R289-1-20240830","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"R290-1-20240830","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2337\/db08-0245","article-title":"Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance","volume":"58","author":"Wilkes","year":"2009","journal-title":"Diabetes"},{"key":"R291-1-20240830","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1469-7793.2000.00237.x","article-title":"Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6","volume":"529","author":"Steensberg","year":"2000","journal-title":"J Physiol"},{"key":"R292-1-20240830","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nm.3549","article-title":"Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis","volume":"20","author":"White","year":"2014","journal-title":"Nat Med"},{"key":"R293-1-20240830","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10777","article-title":"A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis","volume":"481","author":"Bostr\u00f6m","year":"2012","journal-title":"Nature"},{"key":"R294-1-20240830","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.2337\/db16-0356","article-title":"FNDC5 alleviates hepatosteatosis by restoring AMPK\/mTOR-mediated autophagy, fatty acid oxidation, and lipogenesis in mice","volume":"65","author":"Liu","year":"2016","journal-title":"Diabetes"},{"key":"R295-1-20240830","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.7150\/thno.53652","article-title":"NAD+-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5\/irisin","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"R296-1-20240830","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cmet.2013.12.003","article-title":"\u03b2-Aminoisobutyric acid induces browning of white fat and hepatic \u03b2-oxidation and is inversely correlated with cardiometabolic risk factors","volume":"19","author":"Roberts","year":"2014","journal-title":"Cell Metab"},{"key":"R297-1-20240830","doi-asserted-by":"crossref","first-page":"36073","DOI":"10.1074\/jbc.M113.500736","article-title":"Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver","volume":"288","author":"Seldin","year":"2013","journal-title":"J Biol Chem"},{"key":"R298-1-20240830","doi-asserted-by":"crossref","first-page":"8666","DOI":"10.1096\/fj.201900520R","article-title":"Myonectin deletion promotes adipose fat storage and reduces liver steatosis","volume":"33","author":"Little","year":"2019","journal-title":"FASEB J"},{"key":"R299-1-20240830","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2337\/db20-0437","article-title":"Muscular G9a regulates muscle-liver-fat axis by musclin under overnutrition in female mice","volume":"69","author":"Zhang","year":"2020","journal-title":"Diabetes"},{"key":"R300-1-20240830","doi-asserted-by":"crossref","first-page":"19391","DOI":"10.1074\/jbc.C400066200","article-title":"Musclin, a novel skeletal muscle-derived secretory factor","volume":"279","author":"Nishizawa","year":"2004","journal-title":"J Biol Chem"},{"key":"R301-1-20240830","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.32122","article-title":"Up-regulation of thioesterase superfamily member 2 in skeletal muscle promotes hepatic steatosis and insulin resistance in mice","volume":"75","author":"Imai","year":"2022","journal-title":"Hepatology"},{"key":"R302-1-20240830","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/hep.30411","article-title":"Thioesterase superfamily member 2 promotes hepatic VLDL secretion by channeling fatty acids into triglyceride biosynthesis","volume":"70","author":"Alves-Bezerra","year":"2019","journal-title":"Hepatology"},{"key":"R303-1-20240830","doi-asserted-by":"crossref","first-page":"33376","DOI":"10.1074\/jbc.M113.481408","article-title":"Thioesterase superfamily member 2\/Acyl-CoA thioesterase 13 (Them2\/Acot13) regulates adaptive thermogenesis in mice","volume":"288","author":"Kang","year":"2013","journal-title":"J Biol Chem"},{"key":"R304-1-20240830","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1096\/fj.11-202853","article-title":"Thioesterase superfamily member 2\/acyl-CoA thioesterase 13 (Them2\/Acot13) regulates hepatic lipid and glucose metabolism","volume":"26","author":"Kang","year":"2012","journal-title":"FASEB J"},{"key":"R305-1-20240830","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00018-017-2723-6","article-title":"Cardiomyokines from the heart","volume":"75","author":"Chiba","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"R306-1-20240830","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fphar.2020.00877","article-title":"Hydrogen: An endogenous regulator of liver homeostasis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"R307-1-20240830","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1002\/hep.32072","article-title":"Nonalcoholic fatty liver disease and cardiac remodeling risk: Pathophysiological mechanisms and clinical implications","volume":"74","author":"Zhou","year":"2021","journal-title":"Hepatology"},{"key":"R308-1-20240830","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/hep.32021","article-title":"Diagnostic criteria of cirrhotic cardiomyopathy: Out with the old, in with the new?","volume":"74","author":"Liu","year":"2021","journal-title":"Hepatology"},{"key":"R309-1-20240830","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"R310-1-20240830","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.510240226","article-title":"Cirrhotic cardiomyopathy: Getting to the heart of the matter","volume":"24","author":"Ma","year":"1996","journal-title":"Hepatology"},{"key":"R311-1-20240830","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/hep.31907","article-title":"Admission urinary and serum metabolites predict renal outcomes in hospitalized patients with cirrhosis","volume":"74","author":"Bajaj","year":"2021","journal-title":"Hepatology"},{"key":"R312-1-20240830","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"R313-1-20240830","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.3748\/wjg.v27.i26.3984","article-title":"Acute kidney injury and hepatorenal syndrome in cirrhosis","volume":"27","author":"Gupta","year":"2021","journal-title":"World J Gastroenterol"},{"key":"R314-1-20240830","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/hep.32060","article-title":"Metabolomics to predict acute kidney injury in cirrhosis","volume":"74","author":"Piano","year":"2021","journal-title":"Hepatology"},{"key":"R315-1-20240830","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.31443","article-title":"Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features","volume":"72","author":"Zanetto","year":"2020","journal-title":"Hepatology"},{"key":"R316-1-20240830","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/hep.21852","article-title":"Bone disorders in chronic liver disease","volume":"46","author":"Collier","year":"2007","journal-title":"Hepatology"},{"key":"R317-1-20240830","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"R318-1-20240830","doi-asserted-by":"crossref","first-page":"e008910","DOI":"10.1161\/CIRCHEARTFAILURE.121.008910","article-title":"FGF21 (fibroblast growth factor 21) defines a potential cardiohepatic signaling circuit in end-stage heart failure","volume":"15","author":"Sommakia","year":"2022","journal-title":"Circ Heart Fail"},{"key":"R319-1-20240830","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.abn0910","article-title":"Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure","volume":"377","author":"Cao","year":"2022","journal-title":"Science"},{"key":"R320-1-20240830","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1126\/science.ade2538","article-title":"A coagulation factor moonlights in the heart","volume":"377","author":"Tong","year":"2022","journal-title":"Science"},{"key":"R321-1-20240830","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00063-018-0473-3","article-title":"Hepatopulmonary interactions","volume":"113","author":"Fuhrmann","year":"2018","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"R322-1-20240830","first-page":"365","article-title":"Mechanisms of therapeutic effects of rhubarb on gut origin sepsis","volume":"12","author":"Chen","year":"2009","journal-title":"Chin J Traumatol"},{"key":"R323-1-20240830","first-page":"1538","article-title":"The intestine-liver-lung axis in septic syndrome","volume":"121","author":"Pugin","year":"1991","journal-title":"Schweiz Med Wochenschr"},{"key":"R324-1-20240830","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.alcohol.2018.09.001","article-title":"Mesenchymal stem cell treatment attenuates liver and lung inflammation after ethanol intoxication and burn injury","volume":"80","author":"Curtis","year":"2019","journal-title":"Alcohol"},{"key":"R325-1-20240830","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.alcohol.2016.08.005","article-title":"Alcohol and lung injury and immunity","volume":"55","author":"Yeligar","year":"2016","journal-title":"Alcohol"},{"key":"R326-1-20240830","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40635-020-00337-9","article-title":"Liver-lung interactions in acute respiratory distress syndrome","volume":"8","author":"Herrero","year":"2020","journal-title":"Intensive Care Med Exp"},{"key":"R327-1-20240830","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.3390\/biom5042477","article-title":"Potential role of the gut\/liver\/lung axis in alcohol-induced tissue pathology","volume":"5","author":"Massey","year":"2015","journal-title":"Biomolecules"},{"key":"R328-1-20240830","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.1996.03530250054027","article-title":"The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults","volume":"275","author":"Moss","year":"1996","journal-title":"JAMA"},{"key":"R329-1-20240830","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/acer.12855","article-title":"Chronic alcohol exposure enhances lipopolysaccharide-induced lung injury in mice: Potential role of systemic tumor necrosis factor-alpha","volume":"39","author":"Massey","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"R330-1-20240830","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2015-0250PS","article-title":"The gut-liver-lung axis. Modulation of the innate immune response and its possible role in chronic obstructive pulmonary disease","volume":"54","author":"Young","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R331-1-20240830","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/hep.30079","article-title":"Potential clinical targets in hepatopulmonary syndrome: Lessons from experimental models","volume":"68","author":"Raevens","year":"2018","journal-title":"Hepatology"},{"key":"R332-1-20240830","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1183\/09031936.96.09030560","article-title":"Role of NO in the pulmonary artery hyporeactivity to phenylephrine in experimental biliary cirrhosis","volume":"9","author":"Chabot","year":"1996","journal-title":"Eur Respir J"},{"key":"R333-1-20240830","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1053\/gast.1997.v113.pm9247483","article-title":"The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome","volume":"113","author":"Fallon","year":"1997","journal-title":"Gastroenterology"},{"key":"R334-1-20240830","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0168-8278(98)80152-9","article-title":"Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: Correlation with pulmonary dysfunction","volume":"29","author":"Luo","year":"1998","journal-title":"J Hepatol"},{"key":"R335-1-20240830","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1164\/ajrccm.164.5.2009008","article-title":"Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats","volume":"164","author":"Nunes","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R336-1-20240830","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0168-8278(03)00012-6","article-title":"Increased pulmonary vascular endothelin B receptor expression and responsiveness to endothelin-1 in cirrhotic and portal hypertensive rats: A potential mechanism in experimental hepatopulmonary syndrome","volume":"38","author":"Luo","year":"2003","journal-title":"J Hepatol"},{"key":"R337-1-20240830","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.gastro.2003.07.005","article-title":"Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome","volume":"125","author":"Zhang","year":"2003","journal-title":"Gastroenterology"},{"key":"R338-1-20240830","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0168-8278(03)00430-6","article-title":"Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation","volume":"39","author":"Zhang","year":"2003","journal-title":"J Hepatol"},{"key":"R339-1-20240830","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.20244","article-title":"The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat","volume":"39","author":"Ling","year":"2004","journal-title":"Hepatology"},{"key":"R340-1-20240830","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1183\/09031936.04.00080404","article-title":"Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats","volume":"23","author":"Sztrymf","year":"2004","journal-title":"Eur Respir J"},{"key":"R341-1-20240830","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1053\/j.gastro.2004.11.061","article-title":"Carboxyhemoglobin levels in cirrhotic patients with and without hepatopulmonary syndrome","volume":"128","author":"Arguedas","year":"2005","journal-title":"Gastroenterology"},{"key":"R342-1-20240830","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.gastro.2005.05.050","article-title":"Cholangiocyte endothelin 1 and transforming growth factor beta1 production in rat experimental hepatopulmonary syndrome","volume":"129","author":"Luo","year":"2005","journal-title":"Gastroenterology"},{"key":"R343-1-20240830","doi-asserted-by":"crossref","first-page":"L1467","DOI":"10.1152\/ajplung.00446.2006","article-title":"Modulation of pulmonary endothelial endothelin B receptor expression and signaling: Implications for experimental hepatopulmonary syndrome","volume":"292","author":"Tang","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R344-1-20240830","doi-asserted-by":"crossref","first-page":"G704","DOI":"10.1152\/ajpgi.90627.2008","article-title":"Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats","volume":"296","author":"Zhang","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R345-1-20240830","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1164\/rccm.201008-1303OC","article-title":"A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion","volume":"183","author":"Thenappan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R346-1-20240830","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/jgh.13388","article-title":"Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome","volume":"31","author":"Wu","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"R347-1-20240830","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jhep.2012.05.014","article-title":"The role of CX3CL1\/CX3CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome","volume":"57","author":"Zhang","year":"2012","journal-title":"J Hepatol"},{"key":"R348-1-20240830","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2008.12.001","article-title":"Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome","volume":"136","author":"Zhang","year":"2009","journal-title":"Gastroenterology"},{"key":"R349-1-20240830","first-page":"361","article-title":"Serum bile acids in patients with hepatopulmonary syndrome","volume":"55","author":"Horvatits","year":"2017","journal-title":"Z Gastroenterol"},{"key":"R350-1-20240830","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/liv.12655","article-title":"Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury","volume":"35","author":"Chen","year":"2015","journal-title":"Liver Int"},{"key":"R351-1-20240830","doi-asserted-by":"crossref","first-page":"e113451","DOI":"10.1371\/journal.pone.0113451","article-title":"Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS)","volume":"9","author":"Yang","year":"2014","journal-title":"PLoS One"},{"key":"R352-1-20240830","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/hep.31415","article-title":"The myths and realities of portopulmonary hypertension","volume":"72","author":"DuBrock","year":"2020","journal-title":"Hepatology"},{"key":"R353-1-20240830","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(04)16107-2","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome","volume":"363","author":"Hoeper","year":"2004","journal-title":"Lancet"},{"key":"R354-1-20240830","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/hep.26745","article-title":"Pulmonary complications in chronic liver disease","volume":"59","author":"Machicao","year":"2014","journal-title":"Hepatology"},{"key":"R355-1-20240830","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.22378","article-title":"Portopulmonary hypertension","volume":"48","author":"Wells","year":"2008","journal-title":"Hepatology"},{"key":"R356-1-20240830","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.cgh.2020.09.050","article-title":"Diagnosis of hepatopulmonary syndrome in a large integrated health system","volume":"19","author":"Bommena","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R357-1-20240830","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrgastro.2012.123","article-title":"Hepatopulmonary syndrome: Update on pathogenesis and clinical features","volume":"9","author":"Zhang","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R358-1-20240830","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cld.2010.09.005","article-title":"Pulmonary diseases and the liver","volume":"15","author":"Kochar","year":"2011","journal-title":"Clin Liver Dis"},{"key":"R359-1-20240830","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/01.md.0000101573.54295.bd","article-title":"Hypoxic hepatitis: Clinical and hemodynamic study in 142 consecutive cases","volume":"82","author":"Henrion","year":"2003","journal-title":"Medicine (Baltimore"},{"key":"R360-1-20240830","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/hep.510290202","article-title":"Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: A case-controlled, hemodynamic study of 17 consecutive cases","volume":"29","author":"Henrion","year":"1999","journal-title":"Hepatology"},{"key":"R361-1-20240830","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2169\/internalmedicine.46.0059","article-title":"Hypoxic hepatopathy: Pathophysiology and prognosis","volume":"46","author":"Birrer","year":"2007","journal-title":"Intern Med"},{"key":"R362-1-20240830","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.21593","article-title":"Chronic intermittent hypoxia predisposes to liver injury","volume":"45","author":"Savransky","year":"2007","journal-title":"Hepatology"},{"key":"R363-1-20240830","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/0016-5085(95)90659-2","article-title":"Ischemic hepatitis due to obstructive sleep apnea","volume":"109","author":"Mathurin","year":"1995","journal-title":"Gastroenterology"},{"key":"R364-1-20240830","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004836-199706000-00013","article-title":"Hypoxic hepatitis caused by severe hypoxemia from obstructive sleep apnea","volume":"24","author":"Henrion","year":"1997","journal-title":"J Clin Gastroenterol"},{"key":"R365-1-20240830","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s12072-022-10347-2","article-title":"Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity","volume":"16","author":"Fu","year":"2022","journal-title":"Hepatol Int"},{"key":"R366-1-20240830","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.20725","article-title":"Chronic liver injury during obstructive sleep apnea","volume":"41","author":"Tann\u00e9","year":"2005","journal-title":"Hepatology"},{"key":"R367-1-20240830","doi-asserted-by":"crossref","first-page":"100177","DOI":"10.1016\/j.metop.2022.100177","article-title":"Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents","volume":"14","author":"Hazlehurst","year":"2022","journal-title":"Metabol Open"},{"key":"R368-1-20240830","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.118.311282","article-title":"Renin-angiotensin system and cardiovascular functions","volume":"38","author":"Wu","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R369-1-20240830","doi-asserted-by":"crossref","first-page":"R244","DOI":"10.1152\/ajpregu.00323.2011","article-title":"Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice","volume":"302","author":"Yiannikouris","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R370-1-20240830","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1096\/fj.01-0457fje","article-title":"Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation","volume":"15","author":"Massi\u00e9ra","year":"2001","journal-title":"FASEB J"},{"key":"R371-1-20240830","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S1357-2725(96)00086-6","article-title":"Angiotensinogen: Molecular biology, biochemistry and physiology","volume":"28","author":"Morgan","year":"1996","journal-title":"Int J Biochem Cell Biol"},{"key":"R372-1-20240830","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/HYPERTENSIONAHA.115.06040","article-title":"Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice","volume":"66","author":"Yiannikouris","year":"2015","journal-title":"Hypertension"},{"key":"R373-1-20240830","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/ATVBAHA.121.316590","article-title":"Renal angiotensinogen is predominantly liver derived in nonhuman primates","volume":"41","author":"Kukida","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R374-1-20240830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4149\/endo_2013_01_39","article-title":"Renin-angiotensin system: Upgrade of recent knowledge and perspectives","volume":"47","author":"Herichova","year":"2013","journal-title":"Endocr Regul"},{"key":"R375-1-20240830","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1161\/ATVBAHA.113.301777","article-title":"Contributions of leukocyte angiotensin-converting enzyme to development of atherosclerosis","volume":"33","author":"Chen","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R376-1-20240830","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/ATVBAHA.115.307038","article-title":"Angiotensin-converting enzyme in smooth muscle cells promotes atherosclerosis-brief report","volume":"36","author":"Chen","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R377-1-20240830","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/216762a0","article-title":"Conversion of angiotensin I to angiotensin II","volume":"216","author":"Ng","year":"1967","journal-title":"Nature"},{"key":"R378-1-20240830","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R380-1-20240830","doi-asserted-by":"crossref","first-page":"11968","DOI":"10.1073\/pnas.93.21.11968","article-title":"Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: Predominant role of angiotensin III in the control of vasopressin release","volume":"93","author":"Zini","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R381-1-20240830","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.HYP.19.6.692","article-title":"In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats","volume":"19","author":"Yamamoto","year":"1992","journal-title":"Hypertension"},{"key":"R382-1-20240830","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00004872-199107000-00008","article-title":"Evidence that prolyl endopeptidase participates in the processing of brain angiotensin","volume":"9","author":"Welches","year":"1991","journal-title":"J Hypertens"},{"key":"R383-1-20240830","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"R384-1-20240830","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cell.2023.01.039","article-title":"Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic","volume":"186","author":"Oudit","year":"2023","journal-title":"Cell"},{"key":"R385-1-20240830","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"R386-1-20240830","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nat Biotechnol"},{"key":"R387-1-20240830","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"R388-1-20240830","doi-asserted-by":"crossref","first-page":"e9610","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol Syst Biol"},{"key":"R389-1-20240830","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"R390-1-20240830","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"R391-1-20240830","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.120.11941","article-title":"Angiotensin II Type 2 receptor: A target for protection against hypertension, metabolic dysfunction, and organ remodeling","volume":"77","author":"Fatima","year":"2021","journal-title":"Hypertension"},{"key":"R392-1-20240830","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1073\/pnas.0811706106","article-title":"An adrenal beta-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo","volume":"106","author":"Lymperopoulos","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R393-1-20240830","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R394-1-20240830","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4196\/kjpp.2018.22.4.447","article-title":"Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor","volume":"22","author":"Cha","year":"2018","journal-title":"Korean J Physiol Pharmacol"},{"key":"R395-1-20240830","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: A novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ Res"},{"key":"R396-1-20240830","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/ATVBAHA.115.306740","article-title":"Angiotensinogen exerts effects independent of angiotensin II","volume":"36","author":"Lu","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R397-1-20240830","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1194\/jlr.M093252","article-title":"Angiotensinogen in hepatocytes contributes to Western diet-induced liver steatosis","volume":"60","author":"Tao","year":"2019","journal-title":"J Lipid Res"},{"key":"R398-1-20240830","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.120.318075","article-title":"Loss of hepatic angiotensinogen attenuates sepsis-induced myocardial dysfunction","volume":"129","author":"Rong","year":"2021","journal-title":"Circ Res"},{"key":"R399-1-20240830","doi-asserted-by":"crossref","first-page":"41935","DOI":"10.1074\/jbc.M110.150284","article-title":"Intrarenal renin angiotensin system revisited: Role of megalin-dependent endocytosis along the proximal nephron","volume":"285","author":"Pohl","year":"2010","journal-title":"J Biol Chem"},{"key":"R400-1-20240830","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41581-019-0218-4","article-title":"Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"R401-1-20240830","doi-asserted-by":"crossref","first-page":"m2687","DOI":"10.1136\/bmj.m2687","article-title":"Hepatorenal syndrome: Pathophysiology, diagnosis, and management","volume":"370","author":"Simonetto","year":"2020","journal-title":"BMJ"},{"key":"R402-1-20240830","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R403-1-20240830","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"R404-1-20240830","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/ar.a.20086","article-title":"Neural connections between the hypothalamus and the liver","volume":"280","author":"Uyama","year":"2004","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"R405-1-20240830","doi-asserted-by":"crossref","first-page":"101011","DOI":"10.1016\/j.molmet.2020.101011","article-title":"Interaction of glucose sensing and leptin action in the brain","volume":"39","author":"Li","year":"2020","journal-title":"Mol Metab"},{"key":"R406-1-20240830","doi-asserted-by":"crossref","first-page":"108915","DOI":"10.1016\/j.neuropharm.2021.108915","article-title":"Organ and brain crosstalk: The liver-brain axis in gastrointestinal, liver, and pancreatic diseases","volume":"205","author":"Matsubara","year":"2022","journal-title":"Neuropharmacology"},{"key":"R407-1-20240830","doi-asserted-by":"crossref","first-page":"bqab164","DOI":"10.1210\/endocr\/bqab164","article-title":"Pathophysiological mechanisms that alter the autonomic brain-liver communication in metabolic diseases","volume":"162","author":"Silva","year":"2021","journal-title":"Endocrinology"},{"key":"R408-1-20240830","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/434965a","article-title":"Metabolism: A higher power for insulin","volume":"434","author":"Gribble","year":"2005","journal-title":"Nature"},{"key":"R409-1-20240830","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/nature03439","article-title":"Hypothalamic K (ATP) channels control hepatic glucose production","volume":"434","author":"Pocai","year":"2005","journal-title":"Nature"},{"key":"R410-1-20240830","doi-asserted-by":"crossref","first-page":"790S","DOI":"10.3945\/an.115.011171","article-title":"The role of circulating amino acids in the hypothalamic regulation of liver glucose metabolism","volume":"7","author":"Arrieta-Cruz","year":"2016","journal-title":"Adv Nutr"},{"key":"R411-1-20240830","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/db11-0857","article-title":"Hypothalamic leucine metabolism regulates liver glucose production","volume":"61","author":"Su","year":"2012","journal-title":"Diabetes"},{"key":"R412-1-20240830","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/nature06852","article-title":"Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production","volume":"452","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"R413-1-20240830","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nm.3115","article-title":"Hypothalamic glucagon signaling inhibits hepatic glucose production","volume":"19","author":"Mighiu","year":"2013","journal-title":"Nat Med"},{"key":"R414-1-20240830","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cmet.2020.06.008","article-title":"FGF21 signals to glutamatergic neurons in the ventromedial hypothalamus to suppress carbohydrate intake","volume":"32","author":"Jensen-Cody","year":"2020","journal-title":"Cell Metab"},{"key":"R415-1-20240830","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cmet.2021.12.024","article-title":"FGF21 suppresses alcohol consumption through an amygdalo-striatal circuit","volume":"34","author":"Flippo","year":"2022","journal-title":"Cell Metab"},{"key":"R416-1-20240830","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.celrep.2016.02.026","article-title":"Fibroblast growth factor 21 mediates glycemic regulation by hepatic JNK","volume":"14","author":"Vernia","year":"2016","journal-title":"Cell Rep"},{"key":"R417-1-20240830","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1210\/en.2014-2001","article-title":"Central fibroblast growth factor 21 browns white fat via sympathetic action in male mice","volume":"156","author":"Douris","year":"2015","journal-title":"Endocrinology"},{"key":"R418-1-20240830","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s42255-022-00602-z","article-title":"Prolonged breastfeeding protects from obesity by hypothalamic action of hepatic FGF21","volume":"4","author":"Pena-Leon","year":"2022","journal-title":"Nat Metab"},{"key":"R419-1-20240830","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/nm.3250","article-title":"FGF21 contributes to neuroendocrine control of female reproduction","volume":"19","author":"Owen","year":"2013","journal-title":"Nat Med"},{"key":"R420-1-20240830","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nrn3587","article-title":"Hepatic encephalopathy: Effects of liver failure on brain function","volume":"14","author":"Felipo","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"R421-1-20240830","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"R422-1-20240830","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrgastro.2010.116","article-title":"Mechanisms, diagnosis and management of hepatic encephalopathy","volume":"7","author":"Prakash","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R423-1-20240830","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0168-8278(02)00240-4","article-title":"Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure","volume":"37","author":"Jalan","year":"2002","journal-title":"J Hepatol"},{"key":"R424-1-20240830","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.celrep.2019.11.006","article-title":"Liver soluble epoxide hydrolase regulates behavioral and cellular effects of chronic stress","volume":"29","author":"Qin","year":"2019","journal-title":"Cell Rep"},{"key":"R425-1-20240830","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","article-title":"Hepatic soluble epoxide hydrolase activity regulates cerebral A\u03b2 metabolism and the pathogenesis of Alzheimer's disease in mice","volume":"111","author":"Wu","year":"2023","journal-title":"Neuron"},{"key":"R426-1-20240830","doi-asserted-by":"crossref","first-page":"e2301360120","DOI":"10.1073\/pnas.2301360120","article-title":"Enhancement of the liver's neuroprotective role ameliorates traumatic brain injury pathology","volume":"120","author":"Dai","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R427-1-20240830","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1074\/jbc.M112.429258","article-title":"Soluble epoxide hydrolase dimerization is required for hydrolase activity","volume":"288","author":"Nelson","year":"2013","journal-title":"J Biol Chem"},{"key":"R428-1-20240830","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1523\/JNEUROSCI.1246-20.2020","article-title":"14,15-epoxyeicosatrienoic acid alleviates pathology in a mouse model of alzheimer's disease","volume":"40","author":"Chen","year":"2020","journal-title":"J Neurosci"},{"key":"R429-1-20240830","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/hep.32782","article-title":"CD11b+CD43hiLy6Clo splenocyte-derived macrophages exacerbate liver fibrosis via spleen-liver axis","volume":"77","author":"Zhang","year":"2023","journal-title":"Hepatology"},{"key":"R430-1-20240830","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12967-017-1214-8","article-title":"The spleen in liver cirrhosis: Revisiting an old enemy with novel targets","volume":"15","author":"Li","year":"2017","journal-title":"J Transl Med"},{"key":"R431-1-20240830","first-page":"228","article-title":"Hepato-splenic axis: Hepatic and splenic metabolic activities are linked","volume":"8","author":"Keramida","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R432-1-20240830","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1023\/A:1005446418589","article-title":"Spleen enlargement in patients with nonalcoholic fatty liver: Correlation between degree of fatty infiltration in liver and size of spleen","volume":"45","author":"Tsushima","year":"2000","journal-title":"Dig Dis Sci"},{"key":"R433-1-20240830","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/pgmj.45.521.223","article-title":"Hypersplenism in cirrhosis","volume":"45","author":"Blendis","year":"1969","journal-title":"Postgrad Med J"},{"key":"R434-1-20240830","first-page":"85","article-title":"Hypersplenism in liver cirrhosis","volume":"52","author":"Tsuji","year":"1994","journal-title":"Nihon Rinsho"},{"key":"R435-1-20240830","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.7150\/thno.55795","article-title":"Organ-organ communication: The liver's perspective","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"R436-1-20240830","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1440-1746.2002.02667.x","article-title":"Role of the spleen in liver fibrosis in rats may be mediated by transforming growth factor beta-1","volume":"17","author":"Akahoshi","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"R437-1-20240830","first-page":"1407","article-title":"Splenectomy improves liver function in patients with liver cirrhosis","volume":"55","author":"Murata","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"R438-1-20240830","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.surg.2015.05.008","article-title":"Laparoscopic splenectomy for patients with liver cirrhosis: Improvement of liver function in patients with Child-Pugh class B","volume":"158","author":"Yamamoto","year":"2015","journal-title":"Surgery"},{"key":"R439-1-20240830","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s12276-021-00574-2","article-title":"Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK\/TGF-\u03b21 signaling pathway","volume":"53","author":"Liang","year":"2021","journal-title":"Exp Mol Med"},{"key":"R440-1-20240830","doi-asserted-by":"crossref","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","article-title":"Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis","volume":"109","author":"Ramachandran","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R441-1-20240830","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"Karlmark","year":"2009","journal-title":"Hepatology"},{"key":"R442-1-20240830","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2015.05.010","article-title":"Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages","volume":"63","author":"Yada","year":"2015","journal-title":"J Hepatol"},{"key":"R443-1-20240830","doi-asserted-by":"crossref","first-page":"106762","DOI":"10.1016\/j.intimp.2020.106762","article-title":"Splenectomy enhances the Ly6Clow phenotype in hepatic macrophages by activating the ERK1\/2 pathway during liver fibrosis","volume":"86","author":"Zheng","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R444-1-20240830","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00535-015-1054-3","article-title":"Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice","volume":"50","author":"Tanabe","year":"2015","journal-title":"J Gastroenterol"},{"key":"R445-1-20240830","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.advms.2022.02.005","article-title":"Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension","volume":"67","author":"Schwabl","year":"2022","journal-title":"Adv Med Sci"},{"key":"R446-1-20240830","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1080\/10408398.2017.1353479","article-title":"Nutrition, inflammation and liver-spleen axis","volume":"58","author":"Barrea","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R447-1-20240830","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.3748\/wjg.v19.i23.3534","article-title":"Liver-spleen axis: Intersection between immunity, infections and metabolism","volume":"19","author":"Tarantino","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R448-1-20240830","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","article-title":"Liver-spleen axis in nonalcoholic fatty liver disease","volume":"15","author":"Tarantino","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R449-1-20240830","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.3390\/ijms20235878","article-title":"Pemafibrate prevents retinal pathological neovascularization by increasing FGF21 level in a murine oxygen-induced retinopathy model","volume":"20","author":"Tomita","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R450-1-20240830","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.3390\/ijms21176243","article-title":"Pemafibrate protects against retinal dysfunction in a murine model of diabetic retinopathy","volume":"21","author":"Tomita","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R451-1-20240830","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.3390\/ijms22179408","article-title":"Pemafibrate prevents retinal dysfunction in a mouse model of unilateral common carotid artery occlusion","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R452-1-20240830","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41467-020-14499-3","article-title":"Increased circulating levels of Factor H-Related Protein 4 are strongly associated with age-related macular degeneration","volume":"11","author":"Cipriani","year":"2020","journal-title":"Nat Commun"},{"key":"R453-1-20240830","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41586-020-2668-z","article-title":"Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms","volume":"586","author":"Billesb\u00f8lle","year":"2020","journal-title":"Nature"},{"key":"R454-1-20240830","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"R455-1-20240830","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.3390\/ijms22126493","article-title":"Hepcidin-ferroportin interaction controls systemic iron homeostasis","volume":"22","author":"Nemeth","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R456-1-20240830","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00008.2013","article-title":"Systemic iron homeostasis","volume":"93","author":"Ganz","year":"2013","journal-title":"Physiol Rev"},{"key":"R457-1-20240830","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"R458-1-20240830","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.ajpath.2019.05.022","article-title":"Liver-specific, but not retina-specific, hepcidin knockout causes retinal iron accumulation and degeneration","volume":"189","author":"Baumann","year":"2019","journal-title":"Am J Pathol"},{"key":"R459-1-20240830","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.freeradbiomed.2018.07.005","article-title":"Hepatic oxidative stress in pigmented P23H rhodopsin transgenic rats with progressive retinal degeneration","volume":"124","author":"Perdices","year":"2018","journal-title":"Free Radic Biol Med"},{"key":"R460-1-20240830","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3390\/antiox10111853","article-title":"Effects of daily melatonin supplementation on visual loss, circadian rhythms, and hepatic oxidative damage in a rodent model of retinitis pigmentosa","volume":"10","author":"Fuentes-Broto","year":"2021","journal-title":"Antioxidants (Basel"},{"key":"R461-1-20240830","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1572-0241.2001.03778.x","article-title":"Pilot study of bright-light therapy reflected toward the eyes for the pruritus of chronic liver disease","volume":"96","author":"Bergasa","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R462-1-20240830","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mehy.2017.11.002","article-title":"The pruritus of cholestasis: From bile acids to opiate agonists: Relevant after all these years","volume":"110","author":"Bergasa","year":"2018","journal-title":"Med Hypotheses"},{"key":"R463-1-20240830","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/S2589-7500(20)30288-0","article-title":"Screening and identifying hepatobiliary diseases through deep learning using ocular images: A prospective, multicentre study","volume":"3","author":"Xiao","year":"2021","journal-title":"Lancet Digit Health"},{"key":"R464-1-20240830","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Gisondi","year":"2009","journal-title":"J Hepatol"},{"key":"R465-1-20240830","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2009.06.008","article-title":"Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Miele","year":"2009","journal-title":"J Hepatol"},{"key":"R466-1-20240830","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjd.16239","article-title":"Nonalcoholic fatty liver disease in patients with psoriasis: A consequence of systemic inflammatory burden?","volume":"179","author":"Prussick","year":"2018","journal-title":"Br J Dermatol"},{"key":"R467-1-20240830","first-page":"517","article-title":"Non-alcoholic fatty liver disease and psoriasis \u2013 Is there a shared proinflammatory network?","volume":"19","author":"Heitmann","year":"2021","journal-title":"J Dtsch Dermatol Ges"},{"key":"R468-1-20240830","doi-asserted-by":"crossref","first-page":"314","DOI":"10.17235\/reed.2019.6263\/2019","article-title":"Psoriasis and fatty liver: A harmful synergy","volume":"111","author":"Olveira","year":"2019","journal-title":"Rev Esp Enferm Dig"},{"key":"R469-1-20240830","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cmet.2015.09.010","article-title":"A liver-bone endocrine relay by IGFBP1 promotes osteoclastogenesis and mediates FGF21-induced bone resorption","volume":"22","author":"Wang","year":"2015","journal-title":"Cell Metab"},{"key":"R470-1-20240830","doi-asserted-by":"crossref","first-page":"E7554","DOI":"10.1073\/pnas.1607235113","article-title":"Gut microbiota induce IGF-1 and promote bone formation and growth","volume":"113","author":"Yan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R471-1-20240830","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrendo.2016.200","article-title":"Bone: Gut microbiota promote bone growth via IGF1","volume":"13","author":"Ridler","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"R472-1-20240830","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2022.02.006","article-title":"Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression","volume":"34","author":"Lu","year":"2022","journal-title":"Cell Metab"},{"key":"R473-1-20240830","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3390\/ijms20102555","article-title":"Hepatic osteodystrophy-molecular mechanisms proposed to favor its development","volume":"20","author":"Ehnert","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R474-1-20240830","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrgastro.2009.166","article-title":"Current understanding of osteoporosis associated with liver disease","volume":"6","author":"Nakchbandi","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R475-1-20240830","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/ijms23010498","article-title":"Non-alcoholic steatohepatitis (NASH) and organokines: What is now and what will be in the future","volume":"23","author":"Santos","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R476-1-20240830","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00223-016-0210-y","article-title":"Bone-derived factors: A new gateway to regulate glycemia","volume":"100","author":"Bonnet","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"R477-1-20240830","doi-asserted-by":"crossref","first-page":"703310","DOI":"10.3389\/fcell.2021.703310","article-title":"Bacterial translocation as inflammatory driver in crohn's disease","volume":"9","author":"Linares","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R478-1-20240830","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the intestinal microbiome and gut barrier to hepatic disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"R479-1-20240830","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"R480-1-20240830","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41574-022-00641-2","article-title":"Exerkines in health, resilience and disease","volume":"18","author":"Chow","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"R481-1-20240830","doi-asserted-by":"crossref","first-page":"1059020","DOI":"10.3389\/fendo.2023.1059020","article-title":"Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K\/Akt\/mTOR signaling pathway","volume":"14","author":"Arias-Calder\u00f3n","year":"2023","journal-title":"Front Endocrinol (Lausanne"},{"key":"R482-1-20240830","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2020-323715","article-title":"Dietary macronutrients and the gut microbiome: A precision nutrition approach to improve cardiometabolic health","volume":"71","author":"Jardon","year":"2022","journal-title":"Gut"},{"key":"R483-1-20240830","doi-asserted-by":"crossref","first-page":"1194026","DOI":"10.3389\/fphar.2023.1194026","article-title":"Yao-Shan of traditional Chinese medicine: An old story for metabolic health","volume":"14","author":"Yang","year":"2023","journal-title":"Front Pharmacol"}],"container-title":["Chinese Journal of Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/cjop.CJOP-D-22-00131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:20:11Z","timestamp":1787836811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/cjop.CJOP-D-22-00131"}},"subtitle":["From Traditional Chinese Medicine to Western Medicine"],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":473,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/cjop.cjop-d-22-00131","relation":{},"ISSN":["0304-4920"],"issn-type":[{"value":"0304-4920","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}